Improvements in Intractable Lumbar and LowerExtremity Symptoms after Systemic Administration of Tocilizumab, an Anti-interleukin-6 Receptor Antibody. - Sainoh T; Orita S; Miyagi M; Suzuki-Narita M; Sakuma Y; Oikawa Y; Kubota G; Sato J; Shiga Y; Fujimoto K; Eguchi Y; Koda M; et al. (Asian spine journal, 2022)